Circulating cell-free BRAF V600E as a biomarker in children with Langerhans cell histiocytosis-Reference-Cited by-同舟云学术

Circulating cell-free BRAF V600E as a biomarker in children with Langerhans cell histiocytosis

Published:2017-04-25 Issue:3 Volume:178 Page:457-467
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Héritier Sébastien¹²³^ORCID,Hélias-Rodzewicz Zofia²⁴,Lapillonne Hélène⁵,Terrones Nathalie²⁴,Garrigou Sonia⁶,Normand Corinne⁶,Barkaoui Mohamed-Aziz¹,Miron Jean¹,Plat Geneviève⁷,Aladjidi Nathalie⁸,Pagnier Anne⁹,Deville Anne¹⁰,Gillibert-Yvert Marion¹¹,Moshous Despina¹²,Lefèvre-Utile Alain¹²,Lutun Anne¹³,Paillard Catherine¹⁴,Thomas Caroline¹⁵,Jeziorski Eric¹⁶,Nizard Philippe⁶,Taly Valérie⁶,Emile Jean-François²⁴,Donadieu Jean¹²³^ORCID

Affiliation:

1. French Reference Centre for Langerhans Cell Histiocytosis; Trousseau Hospital; Paris France

2. EA4340; UVSQ, Université Paris-Saclay; Boulogne-Billancourt France

3. Department of Paediatric Haematology and Oncology; Trousseau Hospital; Assistance Publique-Hôpitaux de Paris; Paris France

4. Pathology Department; Ambroise Paré Hospital; Assistance Publique-Hôpitaux de Paris; Boulogne-Billancourt France

5. Laboratory of Haematology; Trousseau Hospital; Assistance Publique-Hôpitaux de Paris; Paris France

6. INSERM UMR-S1147; CNRS SNC 5014; Université Paris Sorbonne Cité; Paris France

7. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Toulouse; Toulouse France

8. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Bordeaux; Bordeaux France

9. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Grenoble; Grenoble France

10. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Nice; Nice France

11. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Tours; Tours France

12. Department of Paediatric Immunology; Haematology and Rheumatology; Necker Hospital, Assistance Publique-Hôpitaux de Paris; Paris France

13. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire d'Amiens; Amiens France

14. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Strasbourg; Strasbourg France

15. Department of Paediatric Haematology and Oncology; Centre Hospitalo-Universitaire de Nantes; Nantes France

16. Department of Paediatric; Hôpital Arnaud de Villeneuve; Montpellier France

Funder

Société Française de lutte contre les Cancers de l'Enfant et de l'Adolescent

Fédération Enfants et Santé

Association Recherche et Maladie Hématologiques de l'Enfant

Association Les 111 des Arts de Paris

Association la Petite Maison dans la Prairie

Gardrat family

Association Histiocytose France

InVS

Institut National de la Santé et de la Recherche Médicale

Roche

Centre de Reference des Histiocytoses

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14695/fullpdf

Reference26 articles.

1. How I treat Langerhans cell histiocytosis;Allen;Blood,2015

2. Recurrent BRAF mutations in Langerhans cell histiocytosis;Badalian-Very;Blood,2010

3. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups;Berres;The Journal of Experimental Medicine,2014

4. Overview of circulating nucleic acids in plasma/serum;Butt;Annals of the New York Academy of Sciences,2008

5. Monitoring response to therapy in melanoma by quantifying circulating tumour DNA with droplet digital PCR for BRAF and NRAS mutations;Chang-Hao Tsao;Scientific Reports,2015

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium;Blood Neoplasia;2024-09

2. Targeted Therapy With Vemurafenib in Brazilian Children With Refractory Langerhans Cell Histiocytosis: Two Case Reports and Review of Literature;Cancer Reports;2024-08

3. Current State of Targeted Therapy in Adult Langerhans Cell Histiocytosis and Erdheim–Chester Disease;Targeted Oncology;2024-07-11

4. Vemurafenib combined with cytarabine and cladribine results in clinical efficacy but persistent BRAF^V600E clone in a newborn affected by high‐risk Langerhans cell histiocytosis;British Journal of Haematology;2024-07-10

5. One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas;Veterinary and Comparative Oncology;2024-06-12